Please provide your email address to receive an email when new articles are posted on . Patients receiving roflumilast vs. azithromycin had a reduced risk for COPD exacerbations at 1 year but an ...

Mepolizumab significantly reduced the annualized rate of moderate or severe exacerbations in COPD with an eosinophilic phenotype. Some 20% to 40% of COPD patients have elevated blood eosinophil counts ...

Chronic obstructive pulmonary disease is a condition caused by damage to the lungs that results in breathing difficulties.

I was diagnosed with COPD last year after struggling with multiple symptoms. I quit smoking over 10 years ago, but I’m ...

Columnist Caroline Gainer is no longer haunted by a weight gain that was crucial in helping her adapt to her COPD and to her ...

RedChip Companies will host an investor webinar with Connect Biopharma Holdings Limited (Nasdaq:CNTB) (Connect Biopharma, Connect or the Company), a clinical-stage biopharmaceutical company focused on ...

COPD research needs to increase focus on rural health disparities and consider the impact of sociocultural and environmental exposures on health outcomes, according to a new perspective in the ...

Shashi Tharoor took a poetic dig at Delhi’s worsening pollution, saying, “As November progresses, the burden of performance ...

The pulmonary emphysema market is poised for steady growth driven by rising COPD prevalence, an aging global population, and greater diagnostic awareness. Advances in inhaled therapies, targeted ...

During the peak air pollution months (usually from September to March), the clinics are expected to function for a fixed duration of at least two hours daily.

DEAR DR. ROACH: After over 50 years of smoking, my wife has chronic obstructive pulmonary disease (COPD) and bad scarring of her lungs, but fortunately she doesn’t have cancer. She had respiratory ...